Dicerna Announces Follow-On Public Offering of Common Stock

Go back to Dicerna Announces Follow-On Public Offering of Common Stock

Dicerna Pharma (DRNA) Commences 2.75M Common Follow-on Offering

May 18, 2015 4:08 PM EDT

Dicerna Pharma (NASDAQ: DRNA) announced today the commencement of a proposed underwritten public offering of 2,750,000 shares of common stock. Dicerna also intends to grant the underwriters a 30-day option to purchase up to an additional 412,500 shares of common stock. The offering is subject... More